EP3562486
Notkun á dexmedetómidín undir tungu við meðhöndlun á uppnámi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.12.2017EP published:
13.3.2024EP application number:
17885750.4
EP translation filed:
3.6.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
28.12.2037Expiry date:
28.12.2026Next due date:
31.12.2026
Title in English:
USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATIONLanguage of the patent:
English
Timeline
Today
29.12.2017EP application
13.3.2024EP Publication
3.6.2024Translation submitted
15.7.2024Registration published
28.12.2026Expires
Owner
Name:
BioXcel Therapeutics, Inc.Address:
555 Long Wharf Drive, 5th Floor, New Haven, CT 06511, US
Inventor
Name:
NANDABALAN, KrishnanAddress:
Branford, Connecticut 06405, US
Name:
YOCCA, FrankAddress:
Branford, Connecticut 06405, US
Name:
SHARMA, SameerAddress:
Branford, Connecticut 06405, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662441164 PDate:
31.12.2016Country:
US
Number:
201762471393 PDate:
15.3.2017Country:
US
Number:
201762542323 PDate:
8.8.2017Country:
US
Classification
Categories:
A61K 31/415, A61K 31/4174, A61K 45/06, A61K 47/10, A61P 25/00, A61K 9/20, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 17.12.2024
Expires: 28.12.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 17.12.2025
Expires: 28.12.2026
Payer: Árnason Faktor ehf.